Alto Neuroscience (ANRO) Receivables - Other (2023)

Alto Neuroscience's (ANRO) quarterly Receivables - Other came in at $8000.0 in Q4 2023.

Alto Neuroscience (ANRO) Receivables - Other (2023) Analysis & Trends

Alto Neuroscience has disclosed Receivables - Other across 1 years of filings, most recently posting $8000.0 for Q4 2023.

Receivables - Other for Q4 2023 came in at $8000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $8000.0 (changed N/A YoY), and the FY2023 annual result was $8000.0, changed N/A from the prior year.
Receivables - Other came in at $8000.0 for Q4 2023 at Alto Neuroscience.
In the past five years, Receivables - Other ranged from a high of $8000.0 in Q4 2023 to a low of $8000.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	Alto Neuroscience	643.06 Mn	379.30 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	8,000.00
Dec 31, 2023	8,000.00